Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 815-824

  Weiss, Richard ^a   Dürnberger, Johann ^a   Mostböck, Sven ^a   Scheiblhofer, Sandra ^a   Hartl, Arnulf ^a   Breitenbach, Michael ^a   Strasser, Peter ^a   Dorner, Friedrich ^b   Livey, Ian ^b   Crowe, Brian ^b   Thalhamer, Josef ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

Borreliosis; DNA based immunization; OspC

Indexed keywords

ANTIGEN; CYTOKINE; PLASMID DNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORRELIA; BORRELIA INFECTION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BASE SEQUENCE; BORRELIA; DNA, BACTERIAL; ENDOPLASMIC RETICULUM; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MOLECULAR SEQUENCE DATA; PROTEIN SORTING SIGNALS; SPLEEN;

EID: 0032703778     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00338-2     Document Type: Article

References (39)

1. Wolff J.A. Naked DNA transport and expression in mammalian cells. Neuromuscular Disord. 7:1997;314-318.
2. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
3. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
4. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Ann. Rev. Immunol. 15:1997;617-648.
5. Marconi R.T., Samuels D.S., Garon C.F. Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes. J. Bacteriol. 175:1993;926-932.
6. Sadziene A., Wilske B., Ferdows M.S., Barbour A.G. The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect. Immun. 61:1993;2192-2195.
7. Fuchs R., Jauris S., Lottspeich F., Preac-Mursic V., Wilske B., Soutschek E. Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli. Mol. Microbiol. 6:1992;503-509.
8. Fikrig E., Barthold S.W., Kantor F.S., Flavell R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 250:1990;553-556.
9. Schaible U.E., Wallich R., Kramer M.D., Nerz G., Stehle T., Museteanu C., Simon M.M. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int. Immunol. 6:1994;671-681.
10. Frey A.B., Rao T.D. Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells. Infect. Immun. 63:1995;2596-2603.
11. Zhong W., Gern L., Kramer M., Wallich R., Simon M.M. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection. Eur. J. Immunol. 27:1997;2942-2947.
12. Lengl-Janssen B., Strauss A.F., Steere A.C., Kamradt T. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180:1994;2069-2078.
13. Piesman J., Dolan M.C., Happ C.M., Luft B.J., Rooney S.E., Mather T.N., Golde W.T. Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice. Infect. Immun. 65:1997;4043-4047.
14. Montgomery R.R., Malawista S.E., Feen K.J., Bockenstedt L.K. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183:1996;261-269.
15. de Silva A.M., Telford S.R. 3rd, Brunet L.R., Barthold S.W., Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission- blocking Lyme disease vaccine. J. Exp. Med. 183:1996;271-275.
16. Schwan T.G., Piesman J., Golde W.T., Dolan M.C., Rosa P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA. 92:1995;2909-2913.
17. Zumstein G., Fuchs R., Hofmann A., Preac-Mursic V., Soutschek E., Wilske B. Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi. Med. Microbiol. Immunol. 181:1992;57-70.
18. Wilske B., Busch U., Fingerle V., Jauris-Heipke S., Preac Mursic V., Rossler D., Will G. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection. 24:1996;208-212.
19. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:1995;583-587.
20. Restifo N.P., Bacik I., Irvine K.R., Yewdell J.W., McCabe B.J., Anderson R.W., Eisenlohr L.C., Rosenberg S.A., Bennink J.R. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:1995;4414-4422.
21. Ciernik I.F., Berzofsky J.A., Carbone D.P. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156:1996;2369-2375.
22. Luke C.J., Carner K., Liang X.W., Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:1997;91-97.
23. Davis H.L., Millan C.L., Watkins S.C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4:1997;181-188.
24. Hartl A., Kiesslich J., Weiss R., Bernhaupt A., Mostbock S., Scheiblhofer S., Ebner C., Ferreira F., Thalhamer J. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J. Allergy Clin. Immunol. 103:1999;107-113.
25. Hedstrom R.C., Doolan D.L., Wang R., Kumar A., Sacci J.B. Jr, Gardner M.J., Aguiar J.C., Charoenvit Y., Sedegah M., Tine J.A., Margalith M., Hobart P., Hoffman S.L. In vitro expression and in vivo immunogenicity of plasmodium falciparum pre-erythrocytic stage DNA vaccines [In Process Citation]. Int. J. Mol. Med. 2:1998;29-38.
26. Leitner W.W., Seguin M.C., Ballou W.R., Seitz J.P., Schultz A.M., Sheehy M.J., Lyon J.A. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:1997;6112-6119.
27. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77:1989;61-68.
28. Livey I., Gibbs C.P., Schuster R., Dorner F. Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia. Mol. Microbiol. 18:1995;257-269.
29. Simon M.M., Gern L., Hauser P., Zhong W., Nielsen P.J., Kramer M.D., Brenner C., Wallich R. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 26:1996;2831-2840.
30. Zhong W., Wiesmuller K.H., Kramer M.D., Wallich R., Simon M.M. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur. J. Immunol. 26:1996;2749-2757.
31. Shiver J.W., Davies M.E., Perry H.C., Freed D.C., Liu M.A. Humoral and cellular immunities elicited by HIV-1 DNA vaccination. J. Pharm. Sci. 85:1996;1317-1324.
32. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon gamma. Proc. Natl. Acad. Sci. USA. 93:1996;2879-2883.
33. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635-3639.
34. Kline J.N., Waldschmidt T.J., Businga T.R., Lemish J.E., Weinstock J.V., Thorne P.S., Krieg A.M. Cutting edge: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:1998;2555-2559.
35. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
36. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
37. Sun S.Q., Kishimoto H., Sprent J. DNA as an adjuvant: Capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187:1998;1145-1150.
38. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
39. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 15:1997;788-791.